MED
MEDIFAST INC
NYSE · Consumer Cyclical · Personal Products & Services · US
$12.26
−0.16%Year over year
Reported trailing growth
- Revenue
- -30.3%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- -8.1%
- EBITDA
- +162.2%
- EPS
- +98.6%
Three-year CAGR
- Revenue
- -37.7%
- EBITDA
- -64.7%
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- -80.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2026